These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10432725
21. Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate. Lefebvre I, Périgaud C, Pompon A, Aubertin AM, Girardet JL, Kirn A, Gosselin G, Imbach JL. J Med Chem; 1995 Sep 29; 38(20):3941-50. PubMed ID: 7562927 [Abstract] [Full Text] [Related]
22. Synthesis and anti-HIV activity of some novel arylphosphate and H-phosphonate derivatives of 3'-azido-2',3'-dideoxythymidine and 2',3'-didehydro-2',3'-dideoxythymidine. Cardona VM, Ayi AI, Aubertin AM, Guedj R. Antiviral Res; 1999 Jul 29; 42(3):189-96. PubMed ID: 10443531 [Abstract] [Full Text] [Related]
23. Synthesis and anti-retroviral activity of O,O'-bis(3'-azido-2',3'-dideoxythymidin-5'-yl) phosphoramidate derivatives. Kers I, Stawiński J, Girardet JL, Imbach JL, Périgaud C, Gosselin G, Aubertin AM. Nucleosides Nucleotides; 1999 Oct 29; 18(10):2317-25. PubMed ID: 10616733 [Abstract] [Full Text] [Related]
24. Synthesis, anti-HIV activity, and stability studies of 5'-phosphorofluoridate derivatives of AZT. Egron D, Arzumanov AA, Dyatkina NB, Aubertin AM, Imbach JL, Gosselin G, Krayevsky A, Périgaud C. Bioorg Chem; 2001 Dec 29; 29(6):333-44. PubMed ID: 11846432 [Abstract] [Full Text] [Related]
25. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems. Liotard JF, Mehiri M, Di Giorgio A, Boggetto N, Reboud-Ravaux M, Aubertin AM, Condom R, Patino N. Antivir Chem Chemother; 2006 Dec 29; 17(4):193-213. PubMed ID: 17066898 [Abstract] [Full Text] [Related]
26. AZT 5'-triphosphate nanoformulation suppresses human immunodeficiency virus type 1 replication in peripheral blood mononuclear cells. Saiyed ZM, Gandhi NH, Nair MP. J Neurovirol; 2009 Jul 29; 15(4):343-7. PubMed ID: 19575326 [Abstract] [Full Text] [Related]
33. The M184V mutation reduces the selective excision of zidovudine 5'-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. Boyer PL, Sarafianos SG, Arnold E, Hughes SH. J Virol; 2002 Apr 27; 76(7):3248-56. PubMed ID: 11884549 [Abstract] [Full Text] [Related]
34. Synthesis, lipophilicity and anti-HIV activity of a new brominated analog of zidovudine. Motura M, Salomón H, Moroni G, Wainberg M, Briñón MC. Nucleosides Nucleotides; 1999 Mar 27; 18(3):337-51. PubMed ID: 10358940 [Abstract] [Full Text] [Related]
35. Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors. Schneider A, Corona A, Spöring I, Jordan M, Buchholz B, Maccioni E, Di Santo R, Bodem J, Tramontano E, Wöhrl BM. Nucleic Acids Res; 2016 Mar 18; 44(5):2310-22. PubMed ID: 26850643 [Abstract] [Full Text] [Related]
36. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice. Tan X, Boudinot FD, Chu CK, Egron D, Perigaud C, Gosselin G, Imbach JL. Antivir Chem Chemother; 2000 May 18; 11(3):203-11. PubMed ID: 10901291 [Abstract] [Full Text] [Related]
37. Ether phospholipid-AZT conjugates possessing anti-HIV and antitumor cell activity. Synthesis, conformational analysis, and study of their thermal effects on membrane bilayers. Mavromoustakos T, Calogeropoulou T, Koufaki M, Kolocouris A, Daliani I, Demetzos C, Meng Z, Makriyannis A, Balzarini J, De Clercq E. J Med Chem; 2001 May 24; 44(11):1702-9. PubMed ID: 11356105 [Abstract] [Full Text] [Related]
38. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT). Parang K, Wiebe LI, Knaus EE. Curr Med Chem; 2000 Oct 24; 7(10):995-1039. PubMed ID: 10911016 [Abstract] [Full Text] [Related]
39. Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate. Tan CK, Civil R, Mian AM, So AG, Downey KM. Biochemistry; 1991 May 21; 30(20):4831-5. PubMed ID: 1709809 [Abstract] [Full Text] [Related]
40. New 3'-azido-3'-deoxythymidin-5'-yl O-(4-hydroxyalkyl or -alkenyl or -alkylepoxide) carbonate prodrugs: synthesis and anti-HIV evaluation. Vlieghe P, Clerc T, Pannecouque C, Witvrouw M, De Clercq E, Salles JP, Kraus JL. J Med Chem; 2001 Aug 30; 44(18):3014-21. PubMed ID: 11520210 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]